Learning Hub Central
Gastrointestinal
-1755988787553.webp&w=3840&q=75)
2025 CCC | Esophageal and Gastric Cancer
Gastrointestinal
Non-CME Credit Course
%20(dragged)-1752956736212.webp&w=3840&q=75)
2025 NOSCM | Early Stages Colon Cancer- Use of Biomarkers To Decide Therapy (From MSI to ctDNA)
Gastrointestinal
Non-CME Credit Course
-1752956575380.webp&w=3840&q=75)
2025 NOSCM | Pancreas, Hepatic and Cholangiocarcinoma: Advances in 2025
Gastrointestinal
Non-CME Credit Course
-1752956459196.webp&w=3840&q=75)
2025 NOSCM | Upper GI Cancer: Esophageal and Gastric-New Developments
Gastrointestinal
Non-CME Credit Course
-1750781015824.webp&w=3840&q=75)
2025 MLS Nashville | Updates in Esophageal and Gastric Cancer in 2025
Gastrointestinal
Non-CME Credit Course
2025 MCM | Esophageal and Gastric Cancer: Moving to a More Personalized Approach
Gastrointestinal
Non-CME Credit Course
2025 MCM | After ESMO 2024: What Novel Therapies Are in Use and on Development for Pancreas and Biliary Cancers?
Gastrointestinal
Non-CME Credit Course
2025 MCM | Novel Advances in Colon and Rectal Carcinomas
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Minimally Invasive Pancreatic Resection, Who Benefits?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Neoadjuvant vs Adjuvant Therapy for Resectable Pancreatic Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | State of the Art Imaging in Pancreatic Cancer, What Does Borderline Resectable and Locally Advanced Mean?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Current Therapies for Advanced Pancreatic Neuroendocrine Malignancy
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Familial Pancreatic Cancer—Lessons from Registry Data
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Risk Factors for Pancreatic Cancer, Why is the Incidence Increasing?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Should Pharmacogenomics in Colon Cancer be for Everyone or Not?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Recent Practice Changing Clinical Trials in Colorectal Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Role of Immunotherapy in MSI High Colorectal Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Update on Chemotherapy for Metastatic Colorectal Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Molecular Landscape in Metastatic Colon Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Current Genetics of Hereditary Colon Cancer Syndromes
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Demographics of Colon Cancer Incidence and Early Onset Colorectal Cancer
Gastrointestinal
Non-CME Credit Course
Recent FDA Approved Therapies for Advanced Gastric Cancer, Based on What Studies?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Minimally Invasive Surgery for Gastric Cancer---What does the Data Say?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Endoscopic Submucosal Dissection for Gastric Cancer, Who Benefits?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Gastric Cancer Subtypes and Pathologic Analysis to Guide Treatment for Locally Advance Disease
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Genetics and Management of Hereditary Diffuse Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Stomach Cancer Incidence in Asia, South America and Central America - Implications for the United States
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Classification and Management of Short and Long Term Complications in Esophageal Cancer Surgery
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Robotic Approaches to Surgical Resection in Esophageal Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Which Patients with Esophageal Cancer Should Undergo Chemoradiotherapy without Surgery
Gastrointestinal
Non-CME Credit Course
Management of Precancerous Lesions and Early Esophageal Carcinoma with Endoscopic Advancements
Gastrointestinal
Non-CME Credit Course
Genetic Abnormalities and Active Targets in Esophageal Cancer
Gastrointestinal
Non-CME Credit Course
2025 WCS | Pancreas, Liver and Biliary Tract Malignancies: Updates
Gastrointestinal
Non-CME Credit Course
2025 WCS | Beyond Just Chemotherapy in Colorectal Cancer
Gastrointestinal
Non-CME Credit Course
2025 WCS | New Therapeutic Approaches for Esophageal and Gastric Cancer
Gastrointestinal
Non-CME Credit Course
Esophageal Carcinoma – Finally Something Practice Changing
Gastrointestinal
Non-CME Credit Course
Esophageal and Gastric Carcinomas: Moving the Bar Up after ESMO 2024
Gastrointestinal
Non-CME Credit Course
Latest Advances in Gastrointestinal Cancers
Gastrointestinal
Non-CME Credit Course
New Developments in Esophageal and Gastric Cancer
Gastrointestinal
Non-CME Credit Course
ASCO GI 2024 Updates
Gastrointestinal
Non-CME Credit Course
2025 MCM | Esophageal and Gastric Cancer: Moving to a More Personalized Approach
Gastrointestinal
Non-CME Credit Course
2025 MCM | After ESMO 2024: What Novel Therapies Are in Use and on Development for Pancreas and Biliary Cancers?
Gastrointestinal
Non-CME Credit Course
2025 MCM | Novel Advances in Colon and Rectal Carcinomas
Gastrointestinal
Non-CME Credit Course
2024 MLS Irvine | Pancreatic and Hepatobiliary Updates
Gastrointestinal
Non-CME Credit Course
2024 MLS Irvine | Colon and Esophageal Cancer Updates
Gastrointestinal
Non-CME Credit Course
2024 NOSCM | Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (Against)
Gastrointestinal
Non-CME Credit Course
2024 NOSCM | Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (in Favor)
Gastrointestinal
Non-CME Credit Course
2024 NOSCM | Colorectal Cancer: Novel Treatment Paradigms
Gastrointestinal
Non-CME Credit Course
2024 NOSCM | Pancreas, Hepatic and Cholangiocarcinoma: Advances in 2024
Gastrointestinal
Non-CME Credit Course
2024 NOSCM | Upper GI Cancer: Esophageal and Gastric-New Developments
Gastrointestinal
Non-CME Credit Course
2024 MLS Nashville | Updates in cDNA and Gl Malignancies
Gastrointestinal
Non-CME Credit Course
2024 MLS Cleveland | Neoadjuvant Immunotherapy in Gastrointestinal Cancers
Gastrointestinal
Non-CME Credit Course
Developments in Esophageal and Gastric Tumors
Gastrointestinal
Non-CME Credit Course
2022 AIO | Updates in Gastrointestinal Cancers
Gastrointestinal
Non-CME Credit Course
2024 MCM | Pancreas and Biliary Carcinomas: Novel Advances
Gastrointestinal
Non-CME Credit Course
2024 MCM | How Precision Medicine is Changing Gastric and Esophageal Cancer Management
Gastrointestinal
Non-CME Credit Course
2024 MCM | Colorectal Cancer: Incorporating Molecular Testing and Checkpoint Inhibitors to the Standard of Care
Gastrointestinal
Non-CME Credit Course
How I Treat Metastatic Esophageal and Gastric Cancer in 2023
Gastrointestinal
Non-CME Credit Course
2023 CCC | Advances in Esophageal and Gastric Cancer
Gastrointestinal
Non-CME Credit Course
2023 CCC | Pancreatic and Hepatobiliary Cancer: Emerging Strategies
Gastrointestinal
Non-CME Credit Course
Esophageal, Gastric and GE Junction Tumors: What’s New in 2023?
Gastrointestinal
Non-CME Credit Course
ctDNA in Adjuvant and Metastatic Therapy for GI Cancers: Prime Time?
Gastrointestinal
Non-CME Credit Course
Developments in Gastric, and Esophageal Tumors
Gastrointestinal
Non-CME Credit Course
Establishing IO Management in Gastrointestinal Cancers
Gastrointestinal
Non-CME Credit Course
ASCO GI 2023 Updates
Gastrointestinal
Non-CME Credit Course
Esophageal and Gastric Cancer New Developments
Gastrointestinal
Non-CME Credit Course
2022 NOSCM | Oncology Nurses Role in Clinical Trials and Research for GI Cancer
Gastrointestinal
Non-CME Credit Course
2022 NOSCM | Cholangiocarcinoma/Hepatocellular & Pancreas Cancer
Gastrointestinal
Non-CME Credit Course
2022 NOSCM | Colon and Rectal Cancer: Novel Therapies and Future Approaches
Gastrointestinal
Non-CME Credit Course
2022 NOSCM | Novel Advances for Esophageal, Gastric and GE Junction Tumors
Gastrointestinal
Non-CME Credit Course
2022 NOSCM | Surgical Management of Esophageal & Gastric Cancer
Gastrointestinal
Non-CME Credit Course
2022 MLS Denver | Pancreatic and Esophageal Cancer
Gastrointestinal
Non-CME Credit Course
2022 MLS Nashville | Esophagus and Gastric Cancer Update
Gastrointestinal
Non-CME Credit Course
Gastric and Esophageal Cancer Updates
Gastrointestinal
Non-CME Credit Course
2021 NOSCM | Surgical Management of High-Risk Gastric Patients
Gastrointestinal
Non-CME Credit Course
Gastric, Esophagael, and Circulating Tumor Cells in GI Cancers
Gastrointestinal
Non-CME Credit Course
2021 AIO | State of the Art in Gastrointestinal Cancers + Panel Discussion
Gastrointestinal
Non-CME Credit Course
2021 MCM | Gastrointestinal Malignancies Session
Gastrointestinal
Non-CME Credit Course
Gastric and Esophageal Cancers
Gastrointestinal
Non-CME Credit Course
Gastrointestinal Cancer
Gastrointestinal
Non-CME Credit Course
Optimal Therapeutic Strategies in GI Cancers
Gastrointestinal
Non-CME Credit Course
Upper GI Malignancies - Updates
Gastrointestinal
Non-CME Credit Course
Therapeutic Developments For Neuroendocrine Tumors of the GI Tract and Others
Gastrointestinal
Non-CME Credit Course
Advances in Gastrointestinal Malignancies
Gastrointestinal
Non-CME Credit Course
A Complicated Case of Gastric Cancer
Gastrointestinal
Non-CME Credit Course
Updates in Esophageal and Gastric Cancers
Gastrointestinal
Non-CME Credit Course
Overview of Gastric & Esophageal Cancers
Gastrointestinal
Non-CME Credit Course
2022 WCS | Targeted Therapy for Metastatic Colon Cancers
Gastrointestinal
Non-CME Credit Course
State of the Art in Gastrointestinal Cancers
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Genetic Testing in Pancreatic Cancer
Gastrointestinal
Non-CME Credit Course
Updates in Immunotherapy & Targeted Therapy in Gastrointestinal Cancers Part 2
Gastrointestinal
Non-CME Credit Course
Updates in Immunotherapy & Targeted Therapy in Gastrointestinal Cancers Part 1
Gastrointestinal
Non-CME Credit Course
Immunotherapy in Gastrointestinal Tumors (CRC, Esophageal, and other)
Gastrointestinal
Non-CME Credit Course
Novel Approaches for Early Stages-Locally Advanced Esophageal and GE Junction Tumors
Gastrointestinal
Non-CME Credit Course
Neoadjuvant and Adjuvant Therapies for Esophageal and Gastric Cancers
Gastrointestinal
Non-CME Credit Course
Checkpoint Inhibition in GI Tumors with MSI-H & MMR
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Neoadjuvant, Adjuvant and Systemic Therapy for Advanced Bile Duct Malignancy
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Targeted Therapies in Bile Duct Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Epidemiology and Etiology of HCC and Bile Duct Cancer
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Treatment of Metastatic Pancreatic Cancer---What Direction are We Going?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Is Robotic Surgery the Standard of Care for Colorectal Cancer?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Colon Cancer with Peritoneal Disease—Who Benefits from HIPEC?
Gastrointestinal
Non-CME Credit Course
2025 SFGI | Which Patients with Rectal Cancer can be Managed without Surgery?
Gastrointestinal
Non-CME Credit Course
Contact Us
